Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000238740 | SCV000296912 | uncertain significance | Hypercholesterolemia, familial, 1 | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837787 | SCV000777036 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545271 | SCV001764570 | likely benign | not provided | 2020-11-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19602640) |
Ambry Genetics | RCV003165673 | SCV003876014 | benign | Cardiovascular phenotype | 2023-01-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001545271 | SCV004221663 | benign | not provided | 2022-04-06 | criteria provided, single submitter | clinical testing | |
GENin |
RCV004584641 | SCV005074018 | benign | Familial hypercholesterolemia | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541471 | SCV004772067 | benign | APOB-related disorder | 2019-10-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |